Finland
· Delayed Price · Currency is EUR Optomed Oyj Statistics
Total Valuation
Optomed Oyj has a market cap or net worth of EUR 104.25 million. The enterprise value is 96.26 million.
| Market Cap | 104.25M |
| Enterprise Value | 96.26M |
Important Dates
The last earnings date was Thursday, August 29, 2024.
| Earnings Date | Aug 29, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Optomed Oyj has 19.60 million shares outstanding. The number of shares has increased by 13.01% in one year.
| Shares Outstanding | 19.60M |
| Shares Change (YoY) | +13.01% |
| Shares Change (QoQ) | +2.35% |
| Owned by Insiders (%) | 0.53% |
| Owned by Institutions (%) | 54.92% |
| Float | 14.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.37 |
| PB Ratio | 3.81 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -19.84 |
| EV / Sales | 6.54 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -98.13 |
Financial Position
The company has a current ratio of 3.16, with a Debt / Equity ratio of 16.61.
| Current Ratio | 3.16 |
| Quick Ratio | 2.67 |
| Debt / Equity | 16.61 |
| Debt / EBITDA | n/a |
| Debt / FCF | -4.20 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -22.56% and return on invested capital (ROIC) is -11.60%.
| Return on Equity (ROE) | -22.56% |
| Return on Assets (ROA) | -9.99% |
| Return on Capital (ROIC) | -11.60% |
| Revenue Per Employee | 133,727 |
| Profits Per Employee | -44,118 |
| Employee Count | 114 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 1.69 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +72.90% in the last 52 weeks. The beta is 2.26, so Optomed Oyj's price volatility has been higher than the market average.
| Beta (5Y) | 2.26 |
| 52-Week Price Change | +72.90% |
| 50-Day Moving Average | 5.61 |
| 200-Day Moving Average | 4.63 |
| Relative Strength Index (RSI) | 50.60 |
| Average Volume (20 Days) | 74,492 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Optomed Oyj had revenue of EUR 14.71 million and -4.85 million in losses. Loss per share was -0.28.
| Revenue | 14.71M |
| Gross Profit | 9.97M |
| Operating Income | -4.94M |
| Pretax Income | -4.92M |
| Net Income | -4.85M |
| EBITDA | -4.19M |
| EBIT | -4.94M |
| Loss Per Share | -0.28 |
Balance Sheet
The company has 12.11 million in cash and 4.12 million in debt, giving a net cash position of 7.98 million or 0.41 per share.
| Cash & Cash Equivalents | 12.11M |
| Total Debt | 4.12M |
| Net Cash | 7.98M |
| Net Cash Per Share | 0.41 |
| Equity (Book Value) | 24.82M |
| Book Value Per Share | 1.40 |
| Working Capital | 11.86M |
Cash Flow
In the last 12 months, operating cash flow was -773,000 and capital expenditures -208,000, giving a free cash flow of -981,000.
| Operating Cash Flow | -773,000 |
| Capital Expenditures | -208,000 |
| Free Cash Flow | -981,000 |
| FCF Per Share | -0.05 |
Margins
Gross margin is 67.76%, with operating and profit margins of -33.56% and -32.99%.
| Gross Margin | 67.76% |
| Operating Margin | -33.56% |
| Pretax Margin | -33.47% |
| Profit Margin | -32.99% |
| EBITDA Margin | -28.47% |
| EBIT Margin | -33.56% |
| FCF Margin | -6.67% |
Dividends & Yields
Optomed Oyj does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.01% |
| Shareholder Yield | -13.01% |
| Earnings Yield | -5.18% |
| FCF Yield | -0.94% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |